Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display - Cocktail

911 - Prognostic Nomograms for Predicting Overall and Cancer-Specific Survival in Breast Cancer Patients Not Achieving Pathological Complete Response After Neoadjuvant Chemotherapy

Date

24 Nov 2018

Session

Poster display - Cocktail

Presenters

Jianguo Lai

Citation

Annals of Oncology (2018) 29 (suppl_9): ix8-ix12. 10.1093/annonc/mdy427

Authors

J. Lai1, Z. Pan1, H. Deng1, J. Peng2, P. Chen3, G. Ye3, F. Yu1, K. Chen1, F. Su1

Author affiliations

  • 1 Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 510120 - Guangzhou/CN
  • 2 Department Of Rehabilitation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 510120 - Guangzhou/CN
  • 3 Department Of Breast Surgery, the First People’s Hospital of Foshan, 528000 - Foshan/CN
More

Resources

Abstract 911

Background

This study aimed to construct nomograms for predicting overall survival (OS), breast cancer-specific survival (BCSS) and risk stratification in breast cancer (BC) patients not achieving pathological complete response (pCR) after neoadjuvant chemotherapy (NACT).

Methods

Data on 500 consecutive BC patients who cannot attain pCR after NACT at two independent centers, were respectively collected. Cox proportional hazards regression (CPHR) analysis was implemented to confirm independent prognostic variables for survival. With respect to the discrimination, calibration ability, and clinical utility, we used the C-index, calibration plots and decision curve analysis (DCA) to assess the performance of the nomograms. The predictive accuracy of the models were compared with that of the traditional AJCC TNM staging system using C-index.

Results

On multivariate CPHR analysis, seven determinant factors for survival were pointed out, including age, pathological T stage, pathological N stage, histological grade, ER, Ki67, and lymphovascular invasion. The C-indexs of the established OS- and BCSS-nomograms significantly outperformed than that of the AJCC TNM classification (0.789 vs 0.654; 0.803 vs 0.667, all p < 0.001). The calibration curves shown the good agreements between nomograms prediction and actual observations. Furthermore, DCA demonstrated that both OS- and BCSS-nomograms were superior to the AJCC TNM classification with the wider range of threshold probabilities. The risk stratification on the basis of the OS- and BCSS-nomograms indicated significant differences between Kaplan-Meier curves (p < 0.001).

Conclusions

We established and externally validated nomograms to accurately predict survival outcomes and make effective risk stratification in BC patients not achieving pCR after NACT.

Editorial acknowledgement

Clinical trial identification

Legal entity responsible for the study

Sun Yat-sen Memorial Hospital, Sun Yat-sen University.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings